Protagenic Therapeutics, Inc.\new
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $2.5M | $3.1M |
| FY2017 | — | $1.2M | $399.7K |
| FY2018 | — | $-210.9K | $362.5K |
| FY2019 | — | $-634.4K | $798.6K |
| FY2020 | — | $-1.1M | $671.1K |
| FY2021 | — | $9.9M | — |
| FY2022 | — | $6.9M | — |
| FY2023 | — | $3.7M | — |
| FY2024 | — | $-1.8M | $1.6K |
| FY2025 | — | $-5.0M | $14.5K |